Literature DB >> 1566767

Maternal phenylketonuria collaborative study, obstetric aspects and outcome: the first 6 years.

L D Platt1, R Koch, C Azen, W B Hanley, H L Levy, R Matalon, B Rouse, F de la Cruz, C A Walla.   

Abstract

OBJECTIVE: The purpose of this study was to evaluate the efficacy of a phenylalanine-restricted diet in reducing fetal morbidity associated with maternal hyperphenylalaninemia in women of childbearing age with blood phenylalanine levels greater than 240 mumol/L (greater than 4 mg/dl) on an unrestricted diet. STUDY
DESIGN: Two hundred thirteen pregnant women with hyperphenylalaninemia that resulted in 134 live births have been enrolled in the study. Outcome measures were subject to the chi 2 test, Fisher exact test, analysis of variance, t test, or Wilcoxon nonparametric test for analysis.
RESULTS: Optimal fetal outcome appeared to occur when blood phenylalanine levels less than 600 mumol/L (less than 10 mg/dl) were achieved by 8 to 10 weeks' gestation and maintained throughout pregnancy (trimester averages of less than or equal to 360 mumol/L (less than or equal to 6 mg/dl). Initiation of dietary therapy during the third trimester of pregnancy appears to have little beneficial effect on the fetus.
CONCLUSIONS: Preconceptual counseling and early entrance into a prenatal care program is essential in achieving optimal fetal outcome in women with hyperphenylalaninemia.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1566767     DOI: 10.1016/s0002-9378(11)90601-2

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  8 in total

Review 1.  Indications for fetal echocardiography.

Authors:  M Small; J A Copel
Journal:  Pediatr Cardiol       Date:  2004 May-Jun       Impact factor: 1.655

Review 2.  Genetics of autism: overview and new directions.

Authors:  P Szatmari; M B Jones; L Zwaigenbaum; J E MacLean
Journal:  J Autism Dev Disord       Date:  1998-10

3.  Social factors and the meaning of food in adherence to medical diets: results of a maternal phenylketonuria summer camp.

Authors:  S E Waisbren; H Rokni; I Bailey; F Rohr; T Brown; J Warner-Rogers
Journal:  J Inherit Metab Dis       Date:  1997-03       Impact factor: 4.982

4.  German Maternal Phenylketonuria Study.

Authors:  S Cipcic-Schmidt; F K Trefz; B Fünders; G Seidlitz; K Ullrich
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

5.  The International Collaborative Study on maternal phenylketonuria: organization, study design and description of the sample.

Authors:  E G Friedman; R Koch; C Azen; H Levy; W Hanley; R Matalon; B Rouse; F Trefz; F de la Cruz
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

6.  Psychosocial factors in maternal phenylketonuria: women's adherence to medical recommendations.

Authors:  S E Waisbren; B D Hamilton; P J St James; S Shiloh; H L Levy
Journal:  Am J Public Health       Date:  1995-12       Impact factor: 9.308

Review 7.  Gestational carrier--a reproductive haven for offspring of mothers with phenylketonuria (PKU): an alternative therapy for maternal PKU.

Authors:  R O Fisch; G Tagatz; J P Stassart
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

8.  Reproductive experience of women living with phenylketonuria.

Authors:  Suzanne Ford; Mike O'Driscoll; Anita MacDonald
Journal:  Mol Genet Metab Rep       Date:  2018-11-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.